v3.25.4
Consolidated Balance Sheets (Parentheticals) - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Restricted cash (includes $22,848 and $16,994, respectively, related to consolidated trusts) $ 31,131 $ 25,059
Securities purchased under agreements to resell 45,650 56,250
Total loans held for investment, fair value 5,464 3,744
Accrued interest receivable related to consolidated trusts 11,689 11,364
Accrued interest payable related to consolidated trusts 12,035 11,585
Other liabilities 16,062 15,392
Senior preferred stock, liquidation preference $ 226,984 $ 212,029
Preferred stock, shares authorized (in shares) 700,000,000 700,000,000
Preferred stock, shares outstanding (in shares) 555,374,922 555,374,922
Preferred stock, shares issued (in shares) 555,374,922 555,374,922
Common stock, shares issued (in shares) 1,308,762,703 1,308,762,703
Common stock, shares outstanding (in shares) 1,158,087,567 1,158,087,567
Treasury stock at cost (in shares) 150,675,136 150,675,136
Consolidated Trusts    
Restricted cash (includes $22,848 and $16,994, respectively, related to consolidated trusts) $ 22,848 $ 16,994
Securities purchased under agreements to resell 18,425 14,899
Accrued interest receivable related to consolidated trusts 11,129 10,666
Accrued interest payable related to consolidated trusts 11,320 10,858
Long-term debt 15,060 13,292
Other liabilities 1,719 1,699
Fannie Mae    
Long-term debt $ 256 $ 385